<DOC>
	<DOCNO>NCT02887950</DOCNO>
	<brief_summary>For woman age 55 65 year weight gain major health concern . Obesity important risk factor multiple disease ( e.g . metabolic syndrome , diabetes mellitus , hypertension cardiovascular disease ) , several study show transition menopause associate adverse change body composition . In particular , common observe accumulation adipose tissue abdominal region believe important determinant increase cardiovascular risk . The first-line strategy weight management overweight / obese subject modification dietary habit lifestyle term physical activity . However , nowadays , also grow interest complementary therapy ( i.e . herbal supplement , acupuncture , etc ... ) use alone combination achieve consistent result . In context , preliminary evidence support potential role compound vegetal origin resistant starch , epigallocatechin gallate chlorogenic acid adjuvant dietary therapy overweight . These nutrient may important therapeutic aid overweight subject . However , support use , evidence good quality trial limit .</brief_summary>
	<brief_title>Resistant Starch , Epigallocatechin Gallate Chlorogenic Acid Body Weight Loss Menopause</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Epigallocatechin gallate</mesh_term>
	<criteria>menopause recent onset overweight ( body mass index ≥ 25 ) weight gain ≥ 10 % menopause write informed consent use Orlistat cancer diagnosis unavailability plan measurement</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>